Proteome Sciences Plc Stock Buy Hold or Sell Recommendation
| PMSNF Stock | USD 0.04 0.00 0.00% |
Roughly 55% of Proteome Sciences' stockholders are presently thinking to get in. The analysis of overall sentiment of trading Proteome Sciences plc pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Proteome Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Proteome Sciences plc stock news signals to limit their universe of possible portfolio assets.
Comfort Level 55
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Proteome Sciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Proteome Sciences plc.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentWaiting |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Proteome Sciences plc is 'Cautious Hold'. Macroaxis provides Proteome Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PMSNF positions.
Execute Proteome Sciences Buy or Sell Advice
The Proteome recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Proteome Sciences plc. Macroaxis does not own or have any residual interests in Proteome Sciences plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Proteome Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Fair | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Strong | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Proteome Sciences Trading Alerts and Improvement Suggestions
| Proteome Sciences is way too risky over 90 days horizon | |
| Proteome Sciences has some characteristics of a very speculative penny stock | |
| Proteome Sciences appears to be risky and price may revert if volatility continues | |
| Proteome Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Proteome Sciences plc has accumulated 11.68 M in total debt. Proteome Sciences plc has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Proteome Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Proteome Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proteome Sciences plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proteome to invest in growth at high rates of return. When we think about Proteome Sciences' use of debt, we should always consider it together with cash and equity. | |
| About 21.0% of the company outstanding shares are owned by corporate insiders |
Proteome Sciences Returns Distribution Density
The distribution of Proteome Sciences' historical returns is an attempt to chart the uncertainty of Proteome Sciences' future price movements. The chart of the probability distribution of Proteome Sciences daily returns describes the distribution of returns around its average expected value. We use Proteome Sciences plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Proteome Sciences returns is essential to provide solid investment advice for Proteome Sciences.
| Mean Return | 3.83 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 39.49 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Proteome Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Proteome Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Proteome Sciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Proteome Sciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Proteome pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.96 | |
β | Beta against Dow Jones | 13.12 | |
σ | Overall volatility | 39.49 | |
Ir | Information ratio | 0.1 |
Proteome Sciences Volatility Alert
Proteome Sciences plc is displaying above-average volatility over the selected time horizon. Proteome Sciences plc is a penny stock. Although Proteome Sciences may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Proteome Sciences plc. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Proteome instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Proteome Sciences Fundamentals Vs Peers
Comparing Proteome Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Proteome Sciences' direct or indirect competition across all of the common fundamentals between Proteome Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Proteome Sciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Proteome Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Proteome Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Proteome Sciences to competition |
| Fundamentals | Proteome Sciences | Peer Average |
| Return On Asset | 0.06 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.15 % | (5.51) % |
| Current Valuation | 25.13 M | 16.62 B |
| Shares Outstanding | 295.18 M | 571.82 M |
| Shares Owned By Insiders | 21.49 % | 10.09 % |
| Shares Owned By Institutions | 22.89 % | 39.21 % |
| Price To Earning | 50.00 X | 28.72 X |
| Price To Sales | 2.31 X | 11.42 X |
| Revenue | 5.13 M | 9.43 B |
| Gross Profit | 2.96 M | 27.38 B |
| EBITDA | 625 K | 3.9 B |
| Net Income | 72 K | 570.98 M |
| Cash And Equivalents | 3.2 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 11.68 M | 5.32 B |
| Current Ratio | 0.45 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | 793 K | 971.22 M |
| Number Of Employees | 27 | 18.84 K |
| Beta | 0.0015 | -0.15 |
| Market Capitalization | 14.76 M | 19.03 B |
| Total Asset | 10.04 M | 29.47 B |
| Retained Earnings | (68 M) | 9.33 B |
| Working Capital | (7 M) | 1.48 B |
| Current Asset | 2 M | 9.34 B |
| Current Liabilities | 9 M | 7.9 B |
| Z Score | -7.8 | 8.72 |
| Net Asset | 10.04 M |
Proteome Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Proteome . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Proteome Sciences Buy or Sell Advice
When is the right time to buy or sell Proteome Sciences plc? Buying financial instruments such as Proteome Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Proteome Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Proteome Pink Sheet
Proteome Sciences financial ratios help investors to determine whether Proteome Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Proteome with respect to the benefits of owning Proteome Sciences security.